Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethiopia In-vivo Drug Efficacy Study 2023
PACTR202311879488648Phase 4Completed
- Sponsor
- United States Agency for International Development
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by United States Agency for International Development. Primary endpoint: Adequate clinical and parasitological response. Started Oct 2023; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202311879488648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311879488648.